Credibility Advisory Board

Mike Ashby is a Senior Lecturer at the University of Bristol and the BNA's first Trustee for Credibility in Neuroscience following election by the BNA membership in 2022. His research interests focus on how anatomical and synaptic plasticity coordinate to change the structure and function of neural circuits in the mammalian cortex. For the last nine years, Mike has been a member of the University of Bristol Open Access Steering Committee, which has given him great insight into the importance of open and transparent publication of findings and a passion for increasing use of coding of analytical and modelling tools across neuroscience. Mike has also published on novel statistical methods for limiting potential impact of pseudoreplication in nested, hierarchical experimental design.

Olivia Kowalczyk is a Research Fellow at the Department of Neuroimaging, King's College London and the Wellcome Centre for Human Neuroimaging, UCL. Her interests span a diverse range of topics including spinal fMRI, methods development, neuropharmacology, psychiatry, and meta-science. In her current research work, she focuses on studying the neural underpinnings of pain perception and their pharmacological modulation. Beyond her primary research work, Olivia cultivates her passion for open research by co-organising the RIOT Science Club, a seminar series raising awareness and providing training in reproducible, interpretable, open, and transparent research practices, and by serving as a UKRN Local Network Lead at King's College London.

Kaitlyn Hair is a postdoctoral researcher within the CAMARADES group at the University of Edinburgh. During her PhD, she worked in collaboration with industry and academic partners to conduct large systematic reviews of the evidence from animal models of Alzheimer’s disease. To counter the challenges of this work, she began developing automated tools to help organise and make sense of the vast quantities of published research in this area. She is also a strong advocate for open science practices and is interested in evaluating interventions to improve research quality and reproducibility across biomedical research.

Faisal Mushtaq is a Cognitive Neuroscientist and Director of the Centre for Immersive Technologies at the University of Leeds. Faisal's research sits at the interface between Neuroscience, Psychology, Engineering, and Computer Science. He is founder of the Immersive Cognition Lab which specialises in the study of learning and skill acquisition using virtual environments. With Dr Yuri Pavlov, Faisal co-leads the #EEGManyLabs project, a network of >200 laboratories working on large scale replications of the most influential studies in the field. Faisal is also a member of the Global Brain Consortium, where he is developing methods for large-scale low-cost acquisition of neural data through a novel citizen science methodology. 

Ana Dorrego-Rivas is a research associate at King’s College London. Her research is focused on the development and maintenance of neuronal polarity in vivo and how it impacts neuronal function and integration into brain circuits. Ana is interested in open science practices, preprints and science reproducibility, and advocates for such causes at initiatives like ASAPbio, preLights and eLife Innovation Sprint. 

John Huxter is Associate Director and Cognition Lead at Transpharmation, and is CAB's industry representative. John has had more than 25 years of neuroscience experience in both academia and industry, and across diverse therapeutic areas including psychiatric disorders, chronic pain, and neurodegeneration. With a background in both behaviour and electrophysiology (UCL, University of Bristol, Oxford’s MRC Analytical Neuropharmacology Unit), he has led biomarker discovery and assay development efforts at both Pfizer and Eli Lilly before joining Transpharmation in 2020. John is passionate about the translational potential for preclinical neuroscience, and works closely with the Transpharmation teams in the UK, Ireland, Poland and Canada to explore new opportunities for drug discovery and collaboration. 

Llwyd Orton is Senior Lecturer in Neurophysiology in the Department of Life Sciences at Manchester Metropolitan University. He researches mammalian sensory systems, with particular focus on the relationship between hearing dysfunction and dementia in animal models. He leads the Doctor of Clinical Sciences programme at Manchester Met - a network of over 90 NHS Higher Specialist Scientific Trainees (HSST) across several physiological and life science specialisms. He has developed doctoral level training in open and replicable clinical research study design. He is particularly interested in improving the translation of data from animal models to human studies, as well as meta-science approaches. 

Emily Sena is a Stroke Association Kirby Laing Foundation Senior Non-Clinical Lecturer at the University of Edinburgh. She is specialised in the validity of preclinical research. Her interests are in the use of meta-research approaches (research on research) to drive improvements in the validity, transparency and reproducibility of primary research using animal models of human diseases. Her work has informed laboratory practice guidelines, editorial policy and clinical trials design. Emily is the inaugural Editor-in-Chief of BMJ Open Science, and convenor of CAMARADES.   

Laura studied Pharmacology at King’s College London (including a year in industry with GlaxoSmithKline) before completing her PhD at the Institute for Psychiatry, Psychology and Neuroscience on the topic of ‘the Neuropharmacology of Autism Spectrum Disorders’.

In 2021 Laura was awarded the ‘ELRIG Early Career Impact Award’ for making a ‘significant impact in the drug discovery community’, and in 2022, a prestigious Fellowship to the British Pharmacological Society in recognition of her ongoing contribution to the sector.

Laura has worked across NHS, charity, academic and pharmaceutical research settings to develop strategic cross-sector partnerships and accelerate neuroscience drug discovery efforts in mental health, dementia and motor neurone disease.

Laura is currently Chief Executive of the British Neuroscience Association, where she is responsible for delivering the vision, mission and strategy of the BNA and it’s subsidiary company, BNA Events Ltd.

Tatiana Rosenstock has had an exceptional career and has made significant contributions to the field of Neuroscience for 20+ years. Her work has focused on topics such as mitochondrial deregulation, transcription deregulation, and autophagy in neurodegenerative diseases, such as Huntington’s Disease, and Amyotrophic Lateral Sclerosis, and Schizophrenia.  

At Sygnature Discovery, Tatiana is a Senior Principal Scientist overseeing various neuroscience-related projects in different sub-areas such as metabolism (mitochondrial function), biomarkers, microglial function and activation, and neuroplasticity. During this period, she has been working with distinct in-vitro models, named iPSC-derived neurons, primary cortical neurons, Alzheimer`s and Parkinson`s disease fibroblasts, neuroblastomas cell lines, tissue and biofluids from transgenics animal models of Alzheimer`s disease.